Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2010 Jun 29;9(7):2131–2141. doi: 10.1158/1535-7163.MCT-09-1059

Fig. 2.

Fig. 2

Selection of phage antibodies binding to the CD133+ cell population. A, Outline of the selection scheme. Selection was performed by FACS on cells derived from multiple GBM cases. CD133+ cells were gated by comparing to staining results with an isotype-matched PE-conjugated control mouse mAb. Outputs from round-3 selections were screened to identify monoclonal phage antibodies. B, Patterns of phage antibody binding to GBM cells. Percentage of positive cells is indicated. GBMx8 tumor sphere cells were used in the analysis.